ACM
ABBV icon

Altrius Capital Management’s AbbVie ABBV Stock Holding History

Altrius Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.43M Buy
24,950
+448
+2% +$99.4K 1.08% 54
2025
Q4 		$5.6M Sell
24,502
-1,348
-5% -$307K 1.19% 38
2025
Q3 		$5.99M Buy
25,850
+99
+0.4% +$20.2K 1.37% 28
2025
Q2 		$4.78M Buy
25,751
+98
+0.4% +$18.2K 1.12% 43
2025
Q1 		$5.37M Buy
25,653
+24
+0.1% +$4.67K 1.31% 33
2024
Q4 		$4.55M Sell
25,629
-244
-0.9% -$44.9K 1.22% 41
2024
Q3 		$5.11M Sell
25,873
-141
-0.5% -$26.3K 1.28% 38
2024
Q2 		$4.46M Buy
26,014
+1,453
+6% +$241K 1.17% 46
2024
Q1 		$4.47M Buy
24,561
+1,431
+6% +$247K 1.13% 43
2023
Q4 		$3.58M Buy
23,130
+431
+2% +$62.8K 1% 57
2023
Q3 		$3.38M Buy
22,699
+537
+2% +$78.8K 1% 51
2023
Q2 		$2.99M Buy
22,162
+631
+3% +$92.5K 0.88% 66
2023
Q1 		$3.43M Buy
21,531
+793
+4% +$121K 1.05% 41
2022
Q4 		$3.35M Sell
20,738
-1,013
-5% -$155K 1.05% 46
2022
Q3 		$2.92M Sell
21,751
-15,224
-41% -$2.18M 1.11% 39
2022
Q2 		$5.66M Buy
+36,975
New +$5.65M 1.84% 2

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Altrius Capital Management's ABBV Position: Q1 2026 in Review

Altrius Capital Management increased its AbbVie (ABBV) stake by 1.8% in Q1 2026, buying an estimated $99.4K and bringing the position to 24,950 shares worth $5.43M. The position accounts for 1.08% of the portfolio, ranked #54.

Altrius Capital Management first reported a position in ABBV in Q2 2022 and has held it in 16 quarters since. The position peaked at $5.99M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Altrius Capital Management held 24,950 shares of AbbVie worth $5.43M as of Q1 2026.
  • Altrius Capital Management bought 448 AbbVie shares in Q1 2026, an estimated $99.4K.
  • AbbVie made up 1.08% of Altrius Capital Management's portfolio in Q1 2026, its #54 holding.
  • Altrius Capital Management first reported a position in AbbVie in Q2 2022 and has held it in 16 quarters since.
  • Altrius Capital Management's AbbVie position peaked at $5.99M in Q3 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Altrius Capital Management's 13F filing for Q1 2026, filed 5 May 2026.